The IBCG25 retreat will bring together global leaders in bladder cancer to advance two high-impact initiatives: • Biomarkers in Urothelial Cancer: Focused on identifying best practices for biomarker discovery and clinical application—from diagnosis and surveillance to treatment and trial endpoints. • IBCG Bladder Toxicity Index (IBCG-BTx): A comprehensive framework to measure bladder-specific toxicity across therapies, including radiation, […]